Stem cell therapy is an area of regenerative medicine that studies whether cells with repair and immune-regulating properties can support the body in conditions where conventional treatment has limits. Mesenchymal Stem Cells (MSCs) are the type most commonly used in clinical practice today, and they are being investigated across neurological, orthopaedic, ophthalmic, renal, hepatic and pulmonary conditions. It is a field where genuine research and overstated marketing sit uncomfortably close together, which is why Stem Cell Cure India evaluates each enquiry from Pakistan on its own merits and tells patients plainly when the evidence does not support travelling.
Most enquiries we receive from Pakistan come after a conventional treatment pathway has run its course — a neurologist who has no further options, a nephrologist preparing a patient for dialysis, an ophthalmologist who has said the vision loss is permanent. Patients want to know three things: whether stem cell therapy could realistically help in their condition, what it would involve, and whether it is worth the cost and travel. An evaluation exists to answer exactly those questions, including when the honest answer is that it is not worth it.
Dr. Tyagi leads regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, laboratory processing, and treatment planning across the full range of conditions assessed at the centre.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, and carries out the general health assessment of every patient arriving from Pakistan before any plan is finalised.
Mesenchymal Stem Cells are studied mainly for anti-inflammatory and immunomodulatory effects, and for signalling activity that may influence the tissue environment around them. What the research does not currently show is the ability to reverse established structural damage: scarred liver tissue, dead optic nerve fibres, lost motor neurons and fibrotic lung tissue are not known to be restored by stem cell therapy or by anything else available today. Anyone offering a cure for such conditions is overstating the evidence. Our position is that stem cell therapy is discussed only as a possible addition to properly delivered conventional care, and only where an individual assessment suggests it is reasonable.
Enquiries are reviewed individually, and a referral back to conventional care is a perfectly normal outcome. Conditions we most commonly assess include:
No. For every condition we assess, stem cell therapy is positioned as a possible addition to conventional care, never as a cure and never as a replacement for treatment already prescribed by your own doctors in Pakistan.
Send your diagnosis, recent reports and a short treatment history by email or WhatsApp. The relevant reports differ by condition, and our team will tell you if anything important is missing before an opinion is given.
Yes. If the reports suggest the condition is too advanced, or that conventional treatment such as dialysis or transplant assessment should take priority, we say so rather than encouraging you to travel.
Typically a consultation, any investigations that need repeating or updating, a discussion of findings, and treatment where the assessment supports it. Most patients are in Delhi for 7 to 10 days.
Yes. Once an evaluation is confirmed we issue the invitation letter and supporting documents required for the Indian Medical Visa application and guide you through the steps.
There is no single price, because the condition, its severity and the plan required all affect it. We quote after reviewing your reports, in USD with an approximate PKR equivalent on request.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Tell us the diagnosis and send whatever reports you have. Our team will review them and give you a straightforward opinion — including if the answer is that travelling would not help.
